Technical Analysis for PETQ - PetIQ, Inc.

Grade Last Price % Change Price Change
A 30.98 -0.03% -0.01
PETQ closed down 0.03 percent on Thursday, October 24, 2024, on 1.61 times normal volume.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Very Strong Up Up Flat

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.62%
1,2,3 Pullback Bullish Bullish Swing Setup 0.62%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.62%
Narrow Range Bar Range Contraction 0.62%
Upper Bollinger Band Walk Strength 0.62%
Bollinger Band Squeeze Range Contraction 0.78%
Narrow Range Bar Range Contraction 0.78%
Three Weeks Tight Range Contraction 0.78%
Upper Bollinger Band Walk Strength 0.78%
BB Squeeze + Upper Band Touch Range Contraction 0.78%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

PetIQ, Inc. Description

PetIQ, Inc. is engaged in manufacturing and distributing pet medication and health and wellness products to the retail channel in the United States. The Company provides retail stores with third-party brands, including Frontline Plus, Heartgard Plus, PetAction Plus, Advecta II, Pet Lock Plus, Pet Lock Max, TruProfen and Heartshield. It distributes the products through veterinarian, retail and e-commerce channels. The Company offers its products in a range of categories, including Rx Medications, OTC Medications and Supplies, and Health and Wellness Products. Rx Medications offering includes heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics and other specialty medications. The Company manufactures Heart Shield Plus, version of Heartgard Plus, which prevents heartworm infection in dogs. The Company also manufactures TruProfen, the version of Rimadyl, which treats arthritis in dogs. OTC Medications and Supplies include flea and tick control products.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Retail Store Pain Drugs Diabetes Antibiotics Dog Control Products Wellness Products Arthritis Insecticide Rheumatology E Commerce Channels Wellness Rimadyl

Is PETQ a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 31.06
52 Week Low 15.09
Average Volume 581,722
200-Day Moving Average 22.34
50-Day Moving Average 30.72
20-Day Moving Average 30.88
10-Day Moving Average 30.93
Average True Range 0.08
RSI (14) 79.92
ADX 62.59
+DI 37.77
-DI 6.95
Chandelier Exit (Long, 3 ATRs) 30.81
Chandelier Exit (Short, 3 ATRs) 30.92
Upper Bollinger Bands 31.01
Lower Bollinger Band 30.75
Percent B (%b) 0.88
BandWidth 0.86
MACD Line 0.19
MACD Signal Line 0.24
MACD Histogram -0.0519
Fundamentals Value
Market Cap 904.24 Million
Num Shares 29.2 Million
EPS 0.44
Price-to-Earnings (P/E) Ratio 70.41
Price-to-Sales 0.51
Price-to-Book 2.20
PEG Ratio 2.03
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 31.01
Resistance 3 (R3) 31.01 31.01 31.01
Resistance 2 (R2) 31.01 31.00 31.01 31.00
Resistance 1 (R1) 30.99 30.99 30.99 30.99 31.00
Pivot Point 30.99 30.99 30.99 30.99 30.99
Support 1 (S1) 30.97 30.98 30.97 30.97 30.96
Support 2 (S2) 30.97 30.97 30.97 30.96
Support 3 (S3) 30.95 30.97 30.96
Support 4 (S4) 30.95